Literature DB >> 21668471

Invasive mammary carcinoma with neuroendocrine differentiation: histological features and diagnostic challenges.

Feng Tang1, Bing Wei, Zhen Tian, Michael Z Gilcrease, Lei Huo, Constance T Albarracin, Erika Resetkova, Hong Zhang, Aysegul Sahin, Jieqing Chen, Hong Bu, Susan Abraham, Yun Wu.   

Abstract

AIMS: The aim of this study was to review the histomorphological features of primary neuroendocrine carcinomas (NEC) of the breast, in order to identify features useful in recognition of this entity for appropriate classification. METHODS AND
RESULTS: 2003 World Health Organization (WHO) classification of tumors of the breast and female genital organs defined NEC of the breast as a subtype of invasive mammary carcinoma in which >50% of the tumor cells express neuroendocrine markers. Seventy-four cases that fulfilled the WHO diagnostic criteria for NEC of the breast, excluding small cell carcinoma and low-grade solid papillary carcinoma with a predominant in-situ component, were identified between 1984 and 2008 from MD Anderson Cancer Center, and were included in the study. NECs of the breast had variable histomorphological features. The most common histologic patterns were papillary (80%) and nested (64%). Mixed growth patterns were common (59%), including admixed ductal component. The tumor cells could be polygonal, round, plasmacytoid, spindled, or with signet ring cell features. The cytoplasm could be granular, eosinophilic, clear, or finely vacuolated. These tumors frequently mimicked invasive or in situ ductal carcinoma, or invasive lobular carcinoma.
CONCLUSIONS: NEC of the breast is underrecognized. Careful attention to cytologic and architectural features can help to identify cases that require further immunophenotypic confirmation for correct tumor classification.
© 2011 Blackwell Publishing Limited.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21668471     DOI: 10.1111/j.1365-2559.2011.03880.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  14 in total

1.  Expression of Insulinoma-Associated Protein 1 (INSM1) and Orthopedia Homeobox (OTP) in Tumors with Neuroendocrine Differentiation at Rare Sites.

Authors:  Madhuchhanda Roy; Darya G Buehler; Ranran Zhang; Michael L Schwalbe; Rebecca M Baus; M Shahriar Salamat; Ricardo V Lloyd; Jason N Rosenbaum
Journal:  Endocr Pathol       Date:  2019-03       Impact factor: 3.943

Review 2.  The classification of neuroendocrine neoplasms of the breast and its clinical relevance.

Authors:  Silvia Uccella
Journal:  Virchows Arch       Date:  2021-10-26       Impact factor: 4.064

3.  Neuroendocrine neoplasms of the breast: diagnostic agreement and impact on outcome.

Authors:  Isabella Castellano; Mauro Papotti; Jasna Metovic; Eliano Cascardi; Silvia Uccella; Roberta Maragliano; Giulia Querzoli; Simona Osella-Abate; Alessandra Pittaro; Stefano La Rosa; Giuseppe Bogina; Paola Cassoni; Caterina Marchiò; Anna Sapino
Journal:  Virchows Arch       Date:  2022-10-15       Impact factor: 4.535

4.  Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breast.

Authors:  Marion Lavigne; Emmanuelle Menet; Jean-Christophe Tille; Marick Lae; Laetitia Fuhrmann; Claire Bonneau; Gabrielle Deniziaut; Samia Melaabi; Charlotte C K Ng; Caterina Marchiò; Roman Rouzier; Ivan Bièche; Anne Vincent-Salomon
Journal:  Mod Pathol       Date:  2017-09-08       Impact factor: 7.842

Review 5.  Neuroendocrine Tumors of the Breast.

Authors:  Daniel W Visscher; Saba Yasir
Journal:  Endocr Pathol       Date:  2017-06       Impact factor: 3.943

6.  Peptide Receptor Radionuclide Therapy (PRRT) in a Patient Affected by Metastatic Breast Cancer with Neuroendocrine Differentiation.

Authors:  Giordano Savelli; Alberto Zaniboni; Francesco Bertagna; Giovanni Bosio; Lutfun Nisa; Carlo Rodella; Giorgio Biasiotto; Giovanni Bettinsoli; Elena Migliorati; Alessia Peli; Roberta Falchi; Francesca Giuffrida; Raffaele Giubbini
Journal:  Breast Care (Basel)       Date:  2012-10       Impact factor: 2.860

Review 7.  Breast cancer with neuroendocrine differentiation: an update based on the latest WHO classification.

Authors:  Julia Y Tsang; Gary M Tse
Journal:  Mod Pathol       Date:  2021-02-02       Impact factor: 7.842

8.  Neuroendocrine Tumors of the Breast: Single-Center Experience.

Authors:  Bermal Hasbay; Hüseyin Özgür Aytaç; Filiz Aka Bolat
Journal:  Eur J Breast Health       Date:  2021-12-30

9.  Primary neuroendocrine breast carcinomas: a retrospective analysis and review of literature.

Authors:  Xin Yang; Youde Cao; Chen Chen; Lin Liu; Cheng Wang; Shengchun Liu
Journal:  Onco Targets Ther       Date:  2017-01-18       Impact factor: 4.147

10.  Locally-advanced primary neuroendocrine carcinoma of the breast: case report and review of the literature.

Authors:  Fernando A Angarita; Jorge L Rodríguez; Eugenio Meek; Jesus O Sánchez; Mauricio Tawil; Lilian Torregrosa
Journal:  World J Surg Oncol       Date:  2013-06-05       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.